← Back
$SERA All transactions

SERA PROGNOSTICS, INC.

A

$ Value

$0

Shares

17,437

Price

$0

Filed

Mar 13

Insider

Name

Inglis Tiffany Eul Davis

Title

Chief Medical Officer

CIK

0002091798

Roles

Officer

Transaction Details

Transaction Date

2026-03-12

Code

A

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

92,437

Footnotes

Each share is represented by a restricted stock unit ("RSU"). These RSUs vest over four years as follows: 1/16 of the original grant amount vests in quarterly installments for four years following the vesting commencement date, which is March 10, 2026, subject to the Reporting Person continuing to provide services to the issuer. | These stock options vest over four years as follows: 1/48 of the original grant amount vests in monthly installments for four years following the vesting commencement date, which is March 10, 2026, subject to the Reporting Person continuing to provide services to the issuer.

Filing Info

Accession No.

0001193125-26-106590

Form Type

4

Issuer CIK

0001534969

Inglis Tiffany Eul Davis's History

Date Ticker Type Value
2026-03-12 SERA A $0
2026-03-12 SERA A $0
2025-10-15 SERA A $0
2025-10-15 SERA A $0

Other Insiders at SERA (90d)

Insider Bought Sold Last
Lawrence Sandra AJ $3K 2026-03-06
Harrison Robert Gardner
Chief Information Officer
$19K 2026-03-11
Kamdar Kim P. 2026-02-04
Jackson Benjamin
General Counsel
$8K 2026-03-12
Boniface John J.
Chief Scientific Officer
$9K 2026-03-11
Kearney Paul
Chief Data Officer
$7K 2026-03-11
Lindgardt Zhenya
Chief Executive Officer
$49K 2026-03-12
Aerts Austin
Chief Financial Officer
$15K 2026-03-12
Anderson Dyaarl Lee Jr.
Chief Commercial Officer
2026-03-12
Inglis Tiffany Eul Davis
Chief Medical Officer
2026-03-12